TB & Outbreaks Week
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of TB & Outbreaks Week
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Ebola Hemorrhagic Fever
Study findings from J.E. Strong et al provide new insights into ebola hemorrhagic fever
January 27th, 2009
According to recent research from Winnipeg, Canada, "Human infections with Ebola virus (EBOV) result in a deadly viral disease known as Ebola hemorrhagic fever. Up to 90% of infected patients die, and there is no available treatment or vaccine." "The sporadic human outbreaks are believed to result when EBOV ''jumps'' from an infected animal to a person and is subsequently transmitted between persons by direct contact with infected blood or body fluids. This study was undertaken to investigate the mechanism by which EBOV can persistently infect and then escape from model cell and animal reservoir systems. We report a model system in which infection of mouse and bat cell...
Source: TB & Outbreaks Week (2009-01-27)
|
